Related Experiment Video
Updated: Jan 21, 2026
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity
Jordan Guillon1,2, Coralie Petit1,2, Bertrand Toutain1,2
1Paul Papin ICO Cancer Center, CRCINA, INSERM, Université de Nantes, Université d'Angers , Angers , France.
Abstract:
Senescence is activated in response to chemotherapy to prevent the propagation of cancer cells. In transformed cells, recent studies have shown that this response is not always definitive and that persistent populations can use senescence as an adaptive pathway to restart proliferation and become more aggressive. Here we discuss the results showing that an incomplete and heterogeneous senescence response plays a key role in chemotherapy resistance. Surviving to successive chemotherapy regimens, chronically existing senescent cells can create a survival niche through paracrine cooperations with neighboring cells. This favors chemotherapy escape of premalignant clones but might also allow the survival of adjacent clones presenting a lower fitness. A better characterization of senescence heterogeneity in transformed cells is therefore necessary. This will help us to understand this incomplete response to therapy and how it could generate clones with increased tumor capacity leading to disease relapse.
Insights
Chemotherapy can trigger a temporary cell senescence, but incomplete responses allow cancer cells to adapt, proliferate, and become more aggressive, leading to relapse.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Cellular senescence is a key response to chemotherapy, intended to halt cancer cell proliferation.
- However, transformed cells can evade permanent senescence, utilizing it as an adaptive mechanism for renewed growth and increased malignancy.
Purpose of the Study:
- To investigate the role of incomplete and heterogeneous senescence in chemotherapy resistance.
- To understand how senescent cells contribute to treatment failure and disease relapse.
Main Methods:
- Analysis of senescence heterogeneity in transformed cells post-chemotherapy.
- Examination of paracrine interactions between senescent and neighboring cells.
Main Results:
- An incomplete and heterogeneous senescence response is crucial for chemotherapy resistance.
- Chronically senescent cells establish survival niches via paracrine signaling, promoting chemotherapy escape.
- This process supports the survival of premalignant and even less fit adjacent clones.
Conclusions:
- Heterogeneity in senescence response is critical for understanding chemotherapy resistance.
- Incomplete senescence can drive tumor recurrence by generating more aggressive cancer cell clones.
- Further characterization of senescence heterogeneity is needed to develop effective therapeutic strategies.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
01:51Mechanisms of Retrovirus-induced Cancers